{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:38:33Z","timestamp":1791639513074,"version":"4.3.4"},"reference-count":63,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,5,1]]},"abstract":"<jats:p>Patients with hypopituitarism have an increased risk of cardiovascular mortality. GH treatment could modify the cardiovascular risk in adults with GH deficiency, but most published clinical trials involved few patients and the results are variable.<\/jats:p>\n               <jats:p>We conducted a systematic review of blinded, randomized, placebo-controlled trials of GH treatment in adult patients with GH deficiency published up to August 2003. Thirty-seven trials were identified. We combined the results for effects on lean and fat body mass; body mass index; triglyceride and cholesterol [high-density lipoprotein, low-density lipoprotein (LDL), and total] levels; blood pressure; glycemia; and insulinemia. Overall effect size was used to evaluate significance, and weighted differences between GH and placebo were used to appreciate the size of the effect.<\/jats:p>\n               <jats:p>GH treatment significantly reduced LDL cholesterol [\u22120.5 (sd 0.3) mmol\/liter], total cholesterol [\u22120.3 (0.3) mmol\/liter], fat mass [\u22123.1 (3.3) kg], and diastolic blood pressure [\u22121.8 (3.8) mm Hg] and significantly increased lean body mass [+2.7 (2.6) kg], fasting plasma glucose [+0.2 (0.1) mmol\/liter], and insulin [+8.7 (7.0) pmol\/liter]. All effect sizes remained significant in trials with low doses and long-duration GH treatment.<\/jats:p>\n               <jats:p>Thus, GH treatment has beneficial effects on lean and fat body mass, total and LDL cholesterol levels, and diastolic blood pressure but reduces insulin sensitivity. The global cardiovascular benefit remains to be determined in large trials with appropriate clinical endpoints.<\/jats:p>","DOI":"10.1210\/jc.2003-030840","type":"journal-article","created":{"date-parts":[[2004,5,5]],"date-time":"2004-05-05T02:58:02Z","timestamp":1083725882000},"page":"2192-2199","source":"Crossref","is-referenced-by-count":296,"title":["Impact of Growth Hormone (GH) Treatment on Cardiovascular Risk Factors in GH-Deficient Adults: A Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials"],"prefix":"10.1210","volume":"89","author":[{"given":"Patrick","family":"Maison","sequence":"first","affiliation":[{"name":"Clinical Pharmacology (P.M.), Clinical Research Unit, Assistance Pubique-Ho\u0302pitaux de Paris, Henri Mondor University Hospital, F-94010 Cre\u0301teil, France"},{"name":"Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale U258 (P.M., M.N.-B., N.H., B.B.), F-94807 Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Griffin","sequence":"additional","affiliation":[{"name":"Institute of Public Health (S.G.), CB2 2SR Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Nicoue-Beglah","sequence":"additional","affiliation":[{"name":"Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale U258 (P.M., M.N.-B., N.H., B.B.), F-94807 Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabila","family":"Haddad","sequence":"additional","affiliation":[{"name":"Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale U258 (P.M., M.N.-B., N.H., B.B.), F-94807 Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley","family":"Balkau","sequence":"additional","affiliation":[{"name":"Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale U258 (P.M., M.N.-B., N.H., B.B.), F-94807 Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Chanson","sequence":"additional","affiliation":[{"name":"Endocrinology and Reproductive Diseases (P.C.), Assistance Publique-Ho\u0302pitaux de Paris, Bice\u0302tre University Hospital, and University Paris XI, F-94275 Le Kremlin-Bice\u0302tre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071617380976000_R1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","article-title":"Premature mortality due to cardiovascular disease in hypopituitarism.","volume":"336","author":"Rosen","year":"1990","journal-title":"Lancet"},{"key":"2020071617380976000_R2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group.","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"key":"2020071617380976000_R3","first-page":"1169","article-title":"The effects of hypopituitarism on life expectancy.","volume":"81","author":"Bates","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617380976000_R4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-2265.1999.00650.x","article-title":"Life expectancy following surgery for pituitary tumours.","volume":"50","author":"Bates","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071617380976000_R5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2265.1992.tb02347.x","article-title":"The growth hormone deficiency syndrome in adults.","volume":"37","author":"Cuneo","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071617380976000_R6","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1210\/jcem.83.2.4594","article-title":"Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee.","volume":"83","author":"Carroll","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617380976000_R7","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1046\/j.1365-2265.1997.1660984.x","article-title":"The safety profile of GH replacement therapy in adults.","volume":"46","author":"Chipman","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071617380976000_R8","first-page":"379","volume":"83","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617380976000_R9","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(92)90054-Q","article-title":"Variance imputation for overviews of clinical trials with continuous response.","volume":"45","author":"Follmann","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"2020071617380976000_R10","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM198912283212605","article-title":"The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency.","volume":"321","author":"Salomon","year":"1989","journal-title":"N Engl J Med"},{"key":"2020071617380976000_R11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2265.1995.tb02601.x","article-title":"Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults.","volume":"42","author":"Beshyah","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071617380976000_R12","first-page":"356","article-title":"The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance.","volume":"80","author":"Beshyah","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617380976000_R13","doi-asserted-by":"crossref","first-page":"883","DOI":"10.7326\/0003-4819-125-11-199612010-00003","article-title":"Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial.","volume":"125","author":"Baum","year":"1996","journal-title":"Ann Intern Med"},{"key":"2020071617380976000_R14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.7326\/0003-4819-133-2-200007180-00010","article-title":"Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial.","volume":"133","author":"Sesmilo","year":"2000","journal-title":"Ann Intern Med"},{"key":"2020071617380976000_R15","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1172\/JCI119095","article-title":"Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study.","volume":"98","author":"Boger","year":"1996","journal-title":"J Clin Invest"},{"key":"2020071617380976000_R16","first-page":"1123","article-title":"Short-term growth hormone (GH) treatment of GH-deficient adults increases body sodium and extracellular water, but not blood pressure.","volume":"81","author":"Hoffman","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617380976000_R17","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1210\/jcem.87.4.8394","article-title":"GH increases extracellular volume by stimulating sodium reabsorption in the distal nephron and preventing pressure natriuresis.","volume":"87","author":"Johannsson","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617380976000_R18","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1037\/0033-2909.93.2.388","article-title":"A random effects model for effect sizes.","volume":"93","author":"Hedges","year":"1983","journal-title":"Psychol Bull"},{"key":"2020071617380976000_R19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test.","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"2020071617380976000_R20","first-page":"82","article-title":"Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group.","volume":"82","author":"Attanasio","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617380976000_R21","first-page":"36","article-title":"Effect of growth hormone on total body potassium, fat-free mass and strength in growth hormone-deficient males.","volume":"16","author":"Bell","year":"1998","journal-title":"J Sports Sci"},{"key":"2020071617380976000_R22","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1210\/jc.2002-020542","article-title":"Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle.","volume":"88","author":"Bramnert","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617380976000_R23","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2265.1994.tb03937.x","article-title":"Cardiovascular and renal effects of growth hormone.","volume":"40","author":"Caidahl","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071617380976000_R24","first-page":"2985","article-title":"The importance of growth hormone in the regulation of erythropoiesis, red cell mass, and plasma volume in adults with growth hormone deficiency.","volume":"82","author":"Christ","year":"1997","journal-title":"J Clin Endocrinal Metab"},{"key":"2020071617380976000_R25","first-page":"307","article-title":"Effects of growth hormone (GH) replacement therapy on very low density lipoprotein apolipoprotein B100 kinetics in patients with adult GH deficiency: a stable isotope study.","volume":"84","author":"Christ","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617380976000_R26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-2265.1999.00751.x","article-title":"Growth hormone (GH) replacement therapy reduces serum sialic acid concentrations in adults with GH-deficiency: a double-blind placebo-controlled study.","volume":"51","author":"Christ","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071617380976000_R27","first-page":"107","article-title":"The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.","volume":"83","author":"Cuneo","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617380976000_R28","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1210\/jcem.87.6.8542","article-title":"Gender-specific responses of lean body composition and nongender-specific cardiac function improvement after GH replacement in GH-deficient adults.","volume":"87","author":"Ezzat","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617380976000_R29","first-page":"4104","article-title":"Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.","volume":"85","author":"Fernholm","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617380976000_R30","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1046\/j.1365-2265.1996.830895.x","article-title":"Low-dose growth hormone replacement lowers plasma leptin and fat stores without affecting body mass index in adults with growth hormone deficiency.","volume":"45","author":"Florkowski","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071617380976000_R31","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/0026-0495(93)90197-V","article-title":"Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency.","volume":"42","author":"Fowelin","year":"1993","journal-title":"Metabolism"},{"key":"2020071617380976000_R32","first-page":"3285","article-title":"Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH-deficient adults: a report of one-year clinical experience.","volume":"82","author":"Hwu","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617380976000_R33","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1365-2265.1996.00820.x","article-title":"Long-term cardiovascular effects of growth hormone treatment in GH-deficient adults. Preliminary data in a small group of patients.","volume":"45","author":"Johannsson","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071617380976000_R34","first-page":"1575","article-title":"The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender.","volume":"81","author":"Johannsson","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617380976000_R35","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-0038-1650594","article-title":"Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.","volume":"76","author":"Johansson","year":"1996","journal-title":"Thromb Haemost"},{"key":"2020071617380976000_R36","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(89)92328-3","article-title":"Beneficial effects of growth hormone treatment in GH-deficient adults.","volume":"1","author":"Jorgensen","year":"1989","journal-title":"Lancet"},{"key":"2020071617380976000_R37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3109\/00365519009091600","article-title":"Growth hormone (GH) therapy in GH-deficient patients. The plasma factor vii von Willebrand factor complex and capillary fragility: a double-blind, placebo-controlled, crossover study.","volume":"50","author":"Jorgensen","year":"1990","journal-title":"Scand J Clin Lab Invest"},{"key":"2020071617380976000_R38","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1046\/j.1365-2265.1998.00498.x","article-title":"The circadian rhythm of leptin is preserved in growth hormone deficient hypopituitary adults.","volume":"48","author":"Kousta","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071617380976000_R39","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1046\/j.1365-2265.1998.00597.x","article-title":"HDL-cholesterol reductions associated with adult growth hormone replacement.","volume":"49","author":"Leese","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071617380976000_R40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0025-7753(03)73599-4","article-title":"Growth hormone deficiency in adults: effects of replacement therapy on body composition and health-related quality of life.","volume":"120","author":"Mesa","year":"2003","journal-title":"Med Clin (Barc)"},{"key":"2020071617380976000_R41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/eje.0.1400011","article-title":"Long-term effects of growth hormone (GH) on body fluid distribution in GH deficient adults: a four months double blind placebo controlled trial.","volume":"140","author":"Moller","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"2020071617380976000_R42","first-page":"552","article-title":"Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood.","volume":"80","author":"Nass","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617380976000_R43","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1530\/eje.0.1370459","article-title":"The effect of recombinant human GH replacement therapy on lipoprotein(a) and other lipid parameters in adults with acquired GH deficiency: results of a double-blind and placebo-controlled trial.","volume":"137","author":"Nolte","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"2020071617380976000_R44","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1054\/ghir.1999.0091","article-title":"The effect of the deterioration of insulin sensitivity on \u03b2-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy.","volume":"9","author":"Rosenfalck","year":"1999","journal-title":"Growth Horm IGF Res"},{"key":"2020071617380976000_R45","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2265.1993.tb00525.x","article-title":"The effects of growth hormone on protein metabolism in adult growth hormone deficient patients.","volume":"38","author":"Russell-Jones","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071617380976000_R46","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2265.1994.tb02555.x","article-title":"The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients.","volume":"41","author":"Russell-Jones","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071617380976000_R47","first-page":"E1050","article-title":"Effect of growth hormone treatment on postprandial protein metabolism in growth hormone-deficient adults","volume":"274","author":"Russell-Jones","year":"1998","journal-title":"Am J Physiol"},{"key":"2020071617380976000_R48","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/0026-0495(93)90145-E","article-title":"Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency.","volume":"42","author":"Cuneo","year":"1993","journal-title":"Metabolism"},{"key":"2020071617380976000_R49","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1365-2265.2002.01514.x","article-title":"Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study.","volume":"56","author":"Smith","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071617380976000_R50","first-page":"492","article-title":"Energy and macronutrient intake in growth hormone-deficient adults: the effect of growth hormone replacement.","volume":"49","author":"Snel","year":"1995","journal-title":"Eur J Clin Nutr"},{"key":"2020071617380976000_R51","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/sj.ijo.0800618","article-title":"The favourable effects of growth hormone (GH) substitution on hypercholesterolaemia in GH-deficient adults are not associated with concomitant reductions in adiposity. A 12 month placebo-controlled study.","volume":"22","author":"Vahl","year":"1998","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2020071617380976000_R52","first-page":"659","article-title":"Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatment.","volume":"80","author":"Valcavi","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617380976000_R53","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0021-9150(97)00110-X","article-title":"The effect of growth hormone replacement therapy for up to 12 months on lipoprotein composition and lipoprotein(a) in growth hormone-deficient adults.","volume":"133","author":"Webster","year":"1997","journal-title":"Atherosclerosis"},{"key":"2020071617380976000_R54","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2265.1992.tb02901.x","article-title":"Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study.","volume":"36","author":"Whitehead","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071617380976000_R55","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1042\/cs0810587","article-title":"Cardiovascular effects of growth hormone treatment in growth-hormone-deficient adults: stimulation of the renin-aldosterone system.","volume":"81","author":"Cuneo","year":"1991","journal-title":"Clin Sci (Colch)"},{"key":"2020071617380976000_R56","first-page":"1329","article-title":"Decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency.","volume":"84","author":"Borson-Chazot","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"2020071617380976000_R57","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000182188","article-title":"Role of growth hormone in fluid homeostasis","volume":"36","author":"Ho","year":"1991","journal-title":"Horm Res"},{"key":"2020071617380976000_R58","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0140-6736(99)04055-6","article-title":"Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment.","volume":"355","author":"Cutfield","year":"2000","journal-title":"Lancet"},{"key":"2020071617380976000_R59","first-page":"975","article-title":"The effect of 3 months of recombinant human growth hormone (GH) therapy on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults: a minimal model analysis.","volume":"79","author":"O\u2019Neal","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617380976000_R60","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0026-0495(99)90077-X","article-title":"Gender difference in the response of growth hormone (GH)-deficient adults to GH therapy.","volume":"48","author":"Hayes","year":"1999","journal-title":"Metabolism"},{"key":"2020071617380976000_R61","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0140-6736(02)09519-3","article-title":"Risk of cancer in patients treated with human pituitary growth hormone in the United Kingdom, 1959\u201385: a cohort study.","volume":"360","author":"Swerdlow","year":"2002","journal-title":"Lancet"},{"key":"2020071617380976000_R62","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2165\/00003495-200060040-00002","article-title":"Role of growth hormone in chronic heart failure. Therapeutic implications.","volume":"60","author":"Volterrani","year":"2000","journal-title":"Drugs"},{"key":"2020071617380976000_R63","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1161\/01.CIR.0000100720.01867.1D","article-title":"Cardiac effects of growth hormone (GH) in adults with GH-deficiency. A meta-analysis.","volume":"108","author":"Maison","year":"2003","journal-title":"Circulation"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/89\/5\/2192\/10743102\/jcem2192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/89\/5\/2192\/10743102\/jcem2192.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T03:33:27Z","timestamp":1594956807000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/89\/5\/2192\/2844366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5,1]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2003-030840","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5,1]]}}}